Business

Mankind Pharma may offer investors a better entry point after its listing

By Dan Neff

Long-term investors may get a better entry point to invest in the company post-listing.

Synopsis

Business: Unlike its peers, Mankind Pharma started in rural India and is now expanding to urban India. The company earns 97% of its revenues from India. It has also been a uniquely successful player in building branded consumer product portfolios. The company is a market leader in multiple categories – male condoms with its brand Manforce, pregnancy detection kits with PregaNews, and emergency contraceptives with its pill Unwanted-72.

ET Intelligence Group: Delhi-based Mankind Pharma, the fourth largest pharmaceutical company in terms of domestic sales, is coming out with an IPO of ₹4,326 crore that is entirely an offer for sale wherein the private equity investors and promoters are selling a part of their stakes.Business: Unlike its peers, Mankind Pharma started in rural India and is now expanding to urban India. The company earns 97% of its revenues from India. It has also

BY

ET Bureau

4 mins read, Last Updated:

  • FONT SIZE

    AbcSmall

    AbcMedium

    AbcLarge

  • SAVE
  • PRINT
  • COMMENT

Uh-oh! This is an exclusive story available for selected readers only.

Worry not. You’re just a step away.

Read this story for free.

Unlock your 30 days free access to ETPrime now.

Login to unlock

*No card details required.

Why ?

  • Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors

  • Stock analysis. Market Research. Industry Trends on 4000+ Stocks

  • Clean experience with
    Minimal Ads

  • Comment & Engage with ET Prime community

  • Exclusive invites to Virtual Events with Industry Leaders

  • A trusted team of Journalists & Analysts who can best filter signal from noise

  • ​Get 1 Year Complimentary Subscription of TOI+ worth Rs.799/-​

For all the latest Business News Click Here 

 For the latest news and updates, follow us on Google News. 

Read original article here

Denial of responsibility! TheDailyCheck is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected] The content will be deleted within 24 hours.

Dan Neff